Resting energy expenditure in the HAART era

AIDS Reader

Volumn 10, Issue 9, 2000, Pages 539-544

  Shevitz, A H ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Energy expenditure; HAART; Metabolism; Viral load

Indexed keywords

ANTIRETROVIRUS AGENT;

BASAL METABOLIC RATE; ENERGY BALANCE; ENERGY EXPENDITURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIPODYSTROPHY; PHYSICAL ACTIVITY; REVIEW; VIRUS LOAD;

EID: 0033814994     PISSN: 10530894     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. Long-term measurement of energy expenditure in man: Direct or indirect calorimetry
2. Resting metabolic rate of the critically ill patient: Measured versus predicted
3. Reappraisal of the resting metabolic rate of normal young men
4. A new predictive equation for resting energy expenditure in healthy individuals
5. Resting metabolic requirements of men and women
6. New method for calculating metabolic rate with special reference to protein metabolism
7. Organ tissue contribution to metabolic rate
8. Prediction of resting energy expenditure from fat-free mass and fat mass
9. Resting metabolic rate is lower in women than in men
10. Skeletal muscle metabolism is a major determinant of resting energy expenditure
11. Resting metabolic rate and protein turnover in apparently healthy elderly Gambian men
12. Predicting body fatness: The body mass index vs estimation by bioelectrical impedance
13. Age variations in the relation of body mass indices to estimates of body fat and muscle mass
14. The changing face of AIDS: Translators needed
15. Uncomplicated starvation versus cancer cachexia
16. Catecholammes: Mediators of the hypermetabolic response to thermal injury
17. Metabolic response to injury and illness: Estimation of energy and protein needs from indirect calorimetry and nitrogen balance
18. Hypermetabolism-organ failure syndrome: A metabolic response to injury
19. Metabolic response to sepsis and trauma
20. Unaltered glucose-induced thermogenesis in Graves' disease
21. Rheumatoid cachexia: Cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation
22. Oxygen consumption and caloric expenditure in surgical patients
23. The contribution of body composition, substrates, and hormones to the variability in energy expenditure and substrate utilization in premenopausal women
24. Exogenous androgens influence body composition and regional body fat distribution in obese postmenopausal women: A clinical research center study
25. Epinephrine sensitivity with respect to metabolic rate and other variables in women
26. Physiological increments in epinephrine stimulate metabolic rate in human
27. Acute effects of marihuana smoking on maximal exercise performance
28. Effects of coca chewing on hormonal and metabolic responses during prolonged submaximal exercise
29. Increased resting energy expenditure in human immunodeficiency virus-infected men
30. Resting energy expenditure, caloric intake, and short-term weight change in human immunodeficiency virus infection and the acquired immunodeficiency syndrome
31. Resting energy expenditure and substrate oxidation in human immunodeficiency virus (HIV)-infected asymptomatic men: HIV affects host metabolism in the early asymptomatic stage
32. Resting energy expenditure is increased in stable, malnourished HIV-infected patients
33. Energy expenditure and wasting in human immunodeficiency virus infection
34. Resting energy expenditure in human immunodeficiency virus-infected patients: Comparison between patients with and without secondary infections
35. Preservation of short-term energy balance in clinically stable patients with AIDS
36. Resting energy expenditure and weight loss in human immunodeficiency virus-infected patients
37. Resting energy expenditure, caloric intake, and short-term weight change in human immunodeficiency virus infection and the acquired immunodeficiency syndrome
38. Determinants of increased energy expenditure in HIV-infected women
39. Energy expenditure in human immunodeficiency virus infection
40. Elevated resting energy expenditure among HIV seropositive persons receiving highly active anti-retroviral therapy
41. Beneficial effects of protease inhibitors on body composition and energy expenditure: A comparison between HIV-infected and AIDS patients
42. Effect of indinavir on HIV-related wasting
43. Tumour necrosis factor receptor levels are linked to the acute-phase response and malnutrition in human-immunodeficiency-virus-infected patients
44. Current approach to the treatment of human immunodeficiency virus-associated weight loss: Pathophysiologic considerations and emerging management strategies
45. Tumor necrosis factor: Immunologic, antitumor, metabolic and cardiovascular activities
46. Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome
47. Metabolic disturbances and wasting in the acquired immunodeficiency syndrome
48. Circulating interferon-alfa levels and hypertriglyceridemia in the acquired immunodeficiency syndrome
49. Plasma cytokines, cytokine antagonists, and disease progression in African women infected with HIV-1
50. Cytokine mediators of metabolic changes in HIV infection
51. Determinants of metabolic rate and body composition in adults with HIV infection
52. Adverse effects of reverse transcriptase inhibitor: Mitochondrial toxicity as common pathway